Uniting oncologists for borderless exchange
Uniting healthcare professionals for
borderless exchange in oncology
All roundtable sessions accredited
Join us forour roundtable in||latest advances in||your questions in||new therapies in||practice changes in||your patient cases in
Lausanne University Hospital
University Cancer Center
University Hospital Zurich
|Welcome & introduction by host||Sabina Berezowska|
|HER2 as a biomarker in breast cancer||Zsuzsanna Varga|
|Treatment considerations for HER2-positive GI-cancers||Florian Lordick|
|Clinical implications of HER2 in lung cancer||Maximilian Hochmair|
In this OncoViews, we will focus on the latest therapy and testing options for HER2+ tumors. Our host Sabina Berezowska welcomes you alongside a leading panel of experts in the field of precision oncology to discuss practice-changing studies and latest approvals in the for HER2+ tumors.
Add this to your calendar
- Google Calendar (Online)
- Outlook Calendar (Open Downloaded File)
- Outlook On Microsoft Office 365 (Online)
- Outlook On The Web (Online)
- Apple Offline Calendar / iCal
When: 5:00 PM - 6:30 PM (CEST)
Do You Have An Account Already?
No need to sign up again: as a verified OncoViewer, you will have access to all our upcoming sessions. Simply login to participate in this session.
First Time On OncoViews?
2 CME Points
SGMO • SSOM • SSMO